Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of AdCh63 ME-TRAP and MVA ME-TRAP malaria vaccines in Gambian adults and children
PACTR201008000221638Unknown
- Sponsor
- University of Oxford
- Start
- Jun 2010
- Modality
- Prophylactic Vaccines → Vaccines & Immunotherapeutics, DNA Vaccines → Plasmid DNA → DNA Therapeutics → Nucleic Acid Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Trial of ChAd63 ME-TRAP and MVA ME-TRAP in malaria (2 arms), sponsored by University of Oxford. Primary endpoints: Local solicited adverse events, Systemic solicited adverse events and 1 more. Status: unknown.
02
Drugs
ChAd63 ME-TRAPMVA ME-TRAP
03
Conditions
malaria
Beyond the preview
Go deeper on PACTR201008000221638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201008000221638.